X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice.

Increased production and deposition of amyloid beta-protein (Abeta) are believed to be key pathogenic events in Alzheimer's disease. As such, routes for lowering cerebral Abeta levels represent potential therapeutic targets for Alzheimer's disease. X11beta is a neuronal adaptor protein that binds to the intracellular domain of the amyloid precursor protein (APP). Overexpression of X11beta inhibits Abeta production in a number of experimental systems. However, whether these changes to APP processing and Abeta production induced by X11beta overexpression also induce beneficial effects to memory and synaptic plasticity are not known. We report here that X11beta-mediated reduction in cerebral Abeta is associated with normalization of both cognition and in vivo long-term potentiation in aged APPswe Tg2576 transgenic mice that model the amyloid pathology of Alzheimer's disease. Overexpression of X11beta itself has no detectable adverse effects upon mouse behaviour. These findings support the notion that modulation of X11beta function represents a therapeutic target for Abeta-mediated neuronal dysfunction in Alzheimer's disease.

Effects of DSP4 and dizolcipine on connectivity of solid E19 cortical grafts to ablated SmI region of adult rats; an in vivo electrophysiological study.

The functional connectivity of an embryonic graft implanted into the lesioned somatosensory cortex and the effect of DSP4 (a selective noradrenergic neurotoxin to noradrenergic terminals) and dizolcipine (a non-competitive NMDA receptor antagonist), was studied electrophysiologically. The forepaw representational area of the rat primary somatosensory cortex was lesioned unilaterally and, 3-4 weeks later, tissue from the same region of E19 rat embryos was implanted into the cavity. At 7-9 months later, the rats were anaesthetized and single unit activity was recorded from the grafts in response to contralateral forepaw, ipsilateral hindpaw and contralateral hindpaw stimulation and compared with that obtained in control rats, in rats pretreated with dizolcipine immediately after lesioning and in rats given DSP4 24 h before transplantation. Neurones within the graft were integrated into the host brain and developed a pattern of representation similar to that of intact rats, but with a reduced proportion of neurones exhibiting short-latency response to contralateral forepaw stimulation and an increased proportion responding to stimulation of more than one paw. Pretreatment with dizolcipine did not increase short-latency responses to stimulation of contralateral forepaw stimulation however pretreatment with DSP4 reduced such responses and increased proportion of inhibitory responses. It was concluded that the noradrenergic system plays an important role in establishing host-graft connectivity. The importance of further pharmacological studies on host-graft connectivity and the relation of such connections to neural plasticity were discussed.

Central noradrenergic blockade prevents autotomy in rat: implication for pharmacological prevention of postdenervation pain syndrome.

Following transection of peripheral nerve, rats exhibit autotomy, which is considered to be the animal model of postdenervation pain syndrome. It has been suggested that phantom limb pain is a result of peripheral denervation leading to reorganization of somatosensory pathways, particularly in the cerebral cortex, which is shown to depend upon central noradrenergic activity. In this study, sciatic and saphenous nerves were sectioned in the left hindpaw of 30 adult rats resulting in complete loss of pain sensation in the hindpaw. A group of rats received normal saline, compared to another group which received N-(2-) Chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) injection 24 h prior to transection. The latter group was also compared to a third group whose central noradrenergic system were also blocked by bilateral injection of 6-OHDA into the ascending noradrenergic bundle 1 week prior to transection. A fourth group received contralateral cortical ablation in addition to peripheral nerve transection and was compared to the first group whose cortex remained intact. The animals were observed daily for 60 days and autotomy was scored in accordance to the system of Wall et al. After 1 week, control animals began to exhibit autotomy. In contrast, autotomy was absent in rats treated with DSP4, similar to rats which received 6-OHDA. Rats which had contralateral cortical ablation showed a considerably delayed onset of autotomy and a reduction in final autotomy scores. We conclude that autotomy, as a model of postdenervation pain syndrome, can be prevented by blockade of noradrenergically mediated cortical reorganization. The clinical implications of this finding are discussed.